Feb. 21, 2024

The National Cancer Institute (NCI) will hold its Co-Clinical Imaging Research Resource Program (CIRP) meeting May 20–21. The meeting, which offers free registration, will focus on how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers; what co-clinical quantitative imaging information is currently available at NCI co-clinical imaging research resources; and applications of co-clinical imaging to oncology precision medicine.

The CIRP network was formed in 2018, based on a trans-NCI initiative, with a joint effort of the Cancer Imaging Program at the Division of Cancer Treatment and Diagnosis, the Division of Cancer Biology, and the Division of Cancer Prevention. The network’s mission is to advance precision medicine by establishing consensus-based best practices for co-clinical quantitative imaging to enable disease detection, risk stratification and assessment/prediction of response to therapy.

The meeting is hybrid, with in-person attendance at NCI’s Shady Grove, MD campus or virtual attendance. A call for posters is open to all CIRP and non-CIRP affiliated investigators pursuing research within the scientific scope of the CIRP network. Poster abstracts are due April 8, and registration for the meeting closes May 6.

For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.


Related ACR News

  • Research Funding and Policy Implications in the Further Consolidated Appropriations Act, 2024

    President Biden signed the Further Consolidated Appropriations Act, 2024 (H.R. 2882) into law March 23, to fund the U.S. Departments of Labor, Education and Health and Human Services and their programs for the remainder of federal fiscal year (FY) 2024.

    Read more
  • ACR Seeks Partners for New ARPA-H Program to Revolutionize Cancer Treatment

    The Advanced Research Projects Agency for Health (ARPA-H) recently announced ADvanced Analysis for Precision cancer Therapy (ADAPT) program, intended to harness advanced technologies and a deep understanding of tumor biology to build cancer biomarkers. ARPA-H will seek proposals to revolutionize new adaptive strategies for treating the evolution of cancer. ADAPT program awardees will be tasked with developing groundbreaking new ways to revolutionize cancer care by bringing science and medicine together to map and target tumor changes that improve survival rates for patients with metastatic cancer.

    Read more
  • NCI to Host Cancer Moonshot Seminar Series

    The National Cancer Institute will showcase research from four different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel (BRP) report. The BRP report describes 10 transformative research recommendations for achieving the Cancer Moonshot's goal of making a decade's worth of progress in cancer prevention, diagnosis and treatment in just five years.

    Read more